Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

In a nutshell Scientists discovered that an enzyme called SSAT1 turns helpful immune cells into harmful ones in psoriasis, ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and ...

Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...

There was the time in 2004 when, in an attempt to break the Cubs’ World Series “curse of the Billy Goat,” the P.T.

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

Textbooks usually depict the epithelial cells encasing the interior and exterior of your body as passive barriers. But ...